tiprankstipranks
Trending News
More News >

Nancy Valente Insider Profile

4 Followers
Nancy Valente, Director at Myovant Sciences, holds 49.17K shares in Xencor (Ticker: XNCR), holds 0.00 shares in Myovant Sciences (Ticker: MYOV). Most recently, Nancy Valente Sold ― shares of Xencor on May 06, 2025 for an estimated value of 50.91K.
tipranks
Nancy Valente

Nancy Valente
Myovant Sciences (MYOV)
Director

Ranked #39,920 out of 102,596 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+23.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$454K
100.00%
A breakdown of Nancy Valente's holdings

Insider Roles

Xencor
(XNCR)
EVP, Chief Development Officer
Roles that Nancy Valente holds in companies

Most Profitable Insider Trade

Stock:
Xencor
(XNCR)
Rating:Informative Sell
Date:May 03, 2024 - May 03, 2025
Return:+53.20%
The most profitable trade made by Nancy Valente

Nancy Valente's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MYOV
Myovant Sciences
Mar 10, 2023
Uninformative Sell
$0.00
Xencor
May 06, 2025
EVP, Chief Development Officer
Informative Sell
50.91K
$454.32K
List of latest transactions for each holding click on a transaction to see Nancy Valente's performance on stock

Nancy Valente insider profile FAQ

What is the percentage of profitable transactions made by Nancy Valente?
The percentage of profitable transactions made by Nancy Valente is 50%.
    What is the average return per transaction made by Nancy Valente?
    The average return per transaction made by Nancy Valente is 23.60%.
      What stocks does Nancy Valente hold?
      Nancy Valente holds: MYOV, XNCR stocks.
        What was Nancy Valente’s latest transaction?
        Nancy Valente latest transaction was an Informative Sell of $50.91K.
          What was Nancy Valente's most profitable transaction?
          Nancy Valente’s most profitable transaction was an Informative Sell of XNCR stock on May 3, 2024. The return on the trade was 53.20%.
            What is Nancy Valente's role in Myovant Sciences?
            Nancy Valente's role in Myovant Sciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.